We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App





Triple COVID-19 Antibody Testing Device Indicates Prior SARS-CoV-2 Infection and If Your Vaccine Worked

By LabMedica International staff writers
Posted on 19 Aug 2021
A new seven-minute COVID-19 antibody testing device can tell you if you have had COVID-19 and if your vaccine worked.

Mantracourt Electronics Limited (Devon, UK) helped engineer the new COVID-19 triple antibody testing device which was designed by Attomarker Ltd. More...
(Exeter, UK) and will tell people whether they have immunity against coronavirus and whether that immunity comes from developing antibodies after infection or the vaccine.

The Triple Antibody Test measures three types of antibodies: IgM – the first-responding antibody raised early in the infection; IgG – the long-lasting antibody, persisting in the blood for possibly six months; and IgA – the antibody released on surfaces of the nose and lungs as the first line of defense. These antibodies attack three different parts of the coronavirus: Nucleocapsid - the protein containing the RNA material inside the virus; Spike Protein – the protein that attaches to the surfaces of our cells when the virus invades; and RBD Protein – the part of the spike protein that docks to our cells leading to neutralizing antibodies.

The Triple Antibody Test tells you whether you have natural antibodies because you have had the infection before and which protect you against infection, or if you have vaccine antibodies to protect you against infection. The results appear in real-time and will be an evolving graph which at the end of the test shows the three antibody levels N, S, and RBD along with CRP. If the test reveals that you have antibodies above pre-pandemic levels, then you have some protection and if the results show that you have antibodies below pre-pandemic levels, then you may not have protection against the virus. The results can be downloaded straight to the Biomark App.

“We started off by building the device for Attomarker, but it quickly became apparent that there were other areas where we could assist to deliver the project such as machine validation testing,” explained Robert Badcock, managing director at Mantracourt. “We undertook pre-compliance testing and discovered the electronics and communication systems in the device could be improved. We designed a new power distribution module, new USB components and a USB hub, as well as replacing several of the specified cables in the unit. Overall, we managed to improve the kit while reducing around 60 per cent of the cost and also reduced noise, which is important from an EMC point of view.”

Related Links:
Mantracourt Electronics Limited
Attomarker Ltd.



Platinum Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Multiplex Genetic Analyzer
MassARRAY Dx Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Signs of multiple sclerosis show up in blood years before symptoms appear (Photo courtesy of vitstudio/Shutterstock)

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.